Biotechnology Sector

In recent years, the intersection of artificial intelligence and oncology has yielded groundbreaking insights into the complex dynamics of tumor microenvironments. A notable study by Xie, Ai, and Liu et al., published in the Journal of Translational Medicine, investigates two distinct immune subtypes characterized by tumor-infiltrating lymphocytes (TILs) in the context of triple-negative breast cancer

In the rapidly evolving landscape of photonics, the integration of three-dimensional (3D) photonic packaging represents a frontier that promises to redefine the capabilities of optical communication and computing systems. A recent breakthrough, articulated by Weninger, Serna, Ranno, and collaborators, unveils cutting-edge progress in the design and implementation of waveguide to waveguide couplers, a crucial component

In recent years, the landscape of healthcare education has been undergoing significant transformations, largely driven by the dynamic nature of the allied health industry. The research conducted by Attrill, Foley, and Brebner explores innovative co-designed practice-placement models that underscore the necessity for adaptive educational approaches in this ever-evolving sector. As healthcare continues to integrate more

In a groundbreaking advancement in orthopedic research, a team of scientists has unveiled a new design of a plate implant that has significant implications for the assessment of bone healing. This innovative device utilizes frequency measurement as a key metric, presenting a novel approach in the biomechanical evaluation of skeletal recovery. The team, which includes

In a groundbreaking advancement poised to reshape the landscape of photonics, researchers have unveiled a novel approach to manipulating light within fiber optic systems using exceptional-point-encirclement emulation. This pioneering technique centers around the concept of exceptional points (EPs), unique degeneracies in non-Hermitian systems where eigenvalues and eigenvectors coalesce, leading to unconventional and highly sensitive physical

In the rapidly evolving landscape of photonics and optical engineering, a groundbreaking study has emerged that reshapes our understanding of how light interacts within microstructured environments. The newly published research by Saetchnikov, Tcherniavskaia, Ostendorf, and colleagues unveils a novel exploitation of mode splitting phenomena within optical microcavities to achieve speckle-free wavelength reconstruction. This innovation not

Researchers in the field of regenerative medicine have recently unveiled groundbreaking advancements in nerve tissue engineering, especially in the context of peripheral nerve injuries. Their innovative work involves the development of multifunctional electrospun nerve conduits composed of polycaprolactone (PCL), carbon nanotubes (CNTs), and epigallocatechin gallate (EGCG). This novel combination has been designed to enhance sciatic

In the ever-evolving landscape of healthcare, the importance of screening methods for cervical cancer has gained heightened attention. Studies around the world are focusing on innovative strategies to enhance early detection and streamline the processes involved in screening. One such examination arises from Tamil Nadu, India, where researchers have scrutinized the transition from Visual Inspection

In the realm of immunology, the search for effective vaccines against infectious diseases and cancer has led to the exploration of epitope-based therapeutics. Epitopes, the specific regions of antigens that are recognized by the immune system, serve as critical components in vaccine development. However, the challenge lies in accurately identifying immunogenic epitopes that elicit a

In recent years, the popularity of liposuction has surged, with millions of individuals seeking this cosmetic surgery as a means to achieve their desired body contours. Liposuction, which entails the removal of fat deposits through suction, is often considered a key solution for body shaping. However, a new study by Park and colleagues sheds light

In a groundbreaking development poised to revolutionize the field of fiber-optic sensing, researchers have introduced an innovative technique known as frequency-comb enabled spectrum-correlation reflectometry. This advanced approach offers remarkable enhancements in distributed sensing capabilities, paving the way for precise, real-time monitoring of a wide array of physical parameters over extensive fiber lengths. The work, led

In the rapidly evolving field of quantum information science, the capacity to store and manipulate light-based quantum states efficiently has emerged as a pivotal challenge. A recent breakthrough by Gómez-López, Ritter, Kim, and their team introduces an innovative method termed “light cages,” a transformative platform promising scalable, multiplexed quantum memories with far-reaching implications for quantum

In a groundbreaking study published in Journal of Translational Medicine, researchers have uncovered the intricate connections between gestational diabetes mellitus (GDM), gestational weight gain, and pregnancy outcomes. The work, led by a team of prominent researchers including Jin, Huang, and Qiu, emphasizes the critical role that GDM plays in moderating the relationship between a woman’s

In a groundbreaking advancement for organic luminescent materials, researchers have unveiled a novel mechanism that harnesses simultaneous delayed fluorescence and phosphorescence within a single organic compound, a feat accomplished by exploiting multiple excited states. This innovative approach, detailed in the recent publication by Dou, Liu, Zhou, and colleagues in Light: Science & Applications, heralds a

In recent years, mental health has garnered increasing attention within the realm of public health, particularly as it intersects with chronic physical conditions among vulnerable populations. A significant area of focus has been the coping mechanisms that older adults employ as they navigate the complexities posed by chronic co-morbidities. A recent study by Ma and

In an era defined by technological advances in the medical field, understanding the nuances of adopting clinical decision support systems (CDSS) has become pivotal, especially in specialties like nephrology. A recent qualitative study, spearheaded by researchers Yang, Cheng, and Kuo, delves into physicians’ perceptions regarding the acceptance of a CDSS designed specifically for anemia management

In a groundbreaking advancement in the realm of metamaterials, researchers have unveiled a new framework known as MetaAI, which leverages the principles of physics alongside advanced computational techniques for the discovery of innovative metasurfaces. This cutting-edge system represents a significant departure from conventional design approaches that typically rely on pre-established specifications. Instead, MetaAI functions as

In recent years, the quest for effective treatments and supplements that can aid cognitive function has captured the attention of both researchers and healthcare enthusiasts. The exploration of natural compounds continues to hold promise, with various dietary supplements emerging for their potential neuroprotective properties. A groundbreaking study has been conducted by a team of scientists,

In a groundbreaking leap forward for soft robotics and adaptive materials, a team of researchers has unveiled a novel class of paintable soft photonic architectures capable of multi-stable light-actuation. This pioneering development, published in the prestigious journal Light: Science & Applications, introduces materials that can be not only applied as a common paint but also

In a groundbreaking development set to redefine the landscape of optical computing, researchers have unveiled a novel model-free optical processor that leverages in situ reinforcement learning combined with proximal policy optimization. This pioneering approach circumvents traditional challenges faced by optical processors by enabling adaptive learning directly within the optical system, heralding a new era of

As 2025 comes to a close, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling like a miracle. The post When biotech makes Christmas miracles happen — second edition  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Windtree Therapeutics has not been shy about its desire to become a revenue-generating company, even when achieving that goal means stepping outside the world of drug development. Now, the company is further divesting itself from biotech, selling its cardiovascular pipeline to Seismic Pharmaceutical Holdings.

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage biotechs in the bunch.

Hope Biosciences has linked its stem cell therapy candidate to improved motor function in Parkinson’s disease patients in a phase 2 trial.

Despite a year of trade tensions, national security strictures and stark warnings about the United States’ waning biotech innovation edge, the fact remains that China is and will likely continue to be a prominent source of innovation for the life sciences industry.

Six people, including a former employee of investment bank Citigroup’s San Francisco office, have been charged in an alleged $41 million insider trading and stock manipulation scheme that involves two biotech companies.

For the third year in a row, Fierce Biotech’s Layoff Tracker is topping the tree as the story with the highest number of reads.

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic lung disease candidate it had once hoped would become a best-in-class treatment.

Two years after Gilead secured the first option on Assembly Biosciences’ entire pipeline, the pharma has decided to pick the first fruits from the pact.

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease, offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.

Dive into the world of biotech cinema this holiday season! Our list of biotech movies offers the perfect blend of science and entertainment. The post The best biotech movies to watch this winter appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Big Pharma-backed Aktis Oncology has announced plans to go public in the latest encouraging sign for those betting on a resurgence in biotech IPOs next year.

Having kicked off the year with a $200 million series A, Windward Bio is ending 2025 splashing out on another clinical-stage drug.

Ipsen may be a recent entrant into the antibody-drug conjugate space, but the French biopharma is continuing to make up for lost time.

A phase 3 study of AstraZeneca’s ceralasertib has missed its primary endpoint, dealing another blow to efforts to use a synthetic lethal mechanism to overcome resistance to immuno-oncology drugs.

AstraZeneca has fronted $100 million to head deeper into the KRAS space, securing the rights to a clinical-stage, multitarget asset from China’s Jacobio Pharma.

Ipsen’s oral small molecule failed to reduce the progression of a genetic disease that gradually turns tendons and ligaments into bone, prompting the pharma to stop the study early.

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts warn. The post U.S. vaccine approvals to undergo overhaul: what do the changes mean?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the sole purpose of developing novel therapies in tandem with the Shanghai-based drugmaker.

Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish biotech’s chance to collect up to $592 million in biobucks.

Today's guest is J&J's Ester in t’Groen and we will discuss what's next for J&J in hematology in 2026—including some exciting readouts. The post Johnson & Johnson’s hematology portfolio: breakthroughs to watch appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Altimmune has shared an update on the metabolic dysfunction-associated steatohepatitis (MASH) study that sank its stock in June. The 48-week readout linked the top dose of the GLP-1/glucagon dual receptor agonist to continued weight loss and improvements on noninvasive measures of liver fibrosis.

Boehringer Ingelheim has turned down its chance to license Nxera Pharma’s phase 2-ready schizophrenia drug candidate, depriving the Japanese drugmaker of a 60 million euro ($70 million) option payment.

Longtime Pfizer R&D chief Kathy Fernando, Ph.D., has left the Big Pharma behind to take on the role of chief business officer at San Diego biotech Replicate Bioscience. There, she’ll work to advance Replicate’s early-stage pipeline of assets built on self-replicating RNA technology.

After a long and strange year, Belgian biotech Galapagos is closing out 2025 with some mixed results for its last remaining immunology asset. The company’s tyrosine kinase 2 inhibitor GLPG3667 met the primary endpoint in a dermatomyositis study, but failed to do the same when tested in systemic lupus erythematosus.

After taking a stab at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical asset and returning to its drug discovery roots.

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial.

Founded by a team of neuropsychiatric-focused Teva alums and the force behind Cobenfy maker Karuna, Syremis Therapeutics is off to the races with a $165 million series A to support the development of a dual M1/M4 agonist in schizophrenia.

Discover eight of the biggest immunology and inflammation (I&I) deals in 2025, from early-stage collaborations to late-stage licensing deals. The post Eight of the biggest immunology and inflammation (I&I) deals in 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens. The post Biotech in 2025: A retrospective  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry leaders. The post Lisbon is calling: the BIO-Europe Startup Spotlight returns in March 2026 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Some companies have had wins in 2025, while others have major milestones coming up. Here are 15 biotechs to watch as we head into 2026. The post Keep an eye on these 15 biotech companies in 2026  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Explore our curated list of biotechnology-themed gifts, ranging from captivating board games to engaging DIY biology kits. The post Fifteen gift ideas for a biotech enthusiast this holiday season appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

In this episode we sit down with Martin Beck, Senior Vice President and Head of the Inflammation Business Unit at Boehringer Ingelheim. The post Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease. The post Promising cure for COPD: Is a breakthrough treatment within reach? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo. The post When AI isn’t enough: How physics is shaping the next wave of drug discovery  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. With the rise of international trade and the... Source

The Complex World of Biologic Drugs: Navigating Patent Applications As a biotech professional, you're likely no stranger to the intricacies of developing life-saving treatments. But when it comes to biologic drugs, the process can be particularly chall... Source

Unlocking the Power of Combination Therapies: Strategies for Successful Patenting As a pharmaceutical professional, you know that combination therapies have revolutionized the treatment of complex diseases. By pairing two or more active ingredients, yo... Source

The Secret to Setting the Right Price for Your Generic Medications As a generic drug manufacturer, you're constantly looking for ways to stay ahead of the competition and bring affordable medications to market. But have you ever wondered how to set the... Source

Unlocking Efficiency in the Generic Drug Supply Chain As the pharmaceutical industry continues to evolve, the generic drug supply chain has become a critical component of ensuring timely and affordable access to life-saving medications. However, naviga... Source

Breaking News: FDA Updates - What Do the Latest Changes Mean for Generic Drug Approval? As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic drug approval. Re... Source

Breaking Down Barriers: Navigating Regulatory Challenges in Latin America's Generic Drug Market As the demand for affordable generic medications continues to grow, Latin America has emerged as a critical region for pharmaceutical companies looking to e... Source

The Future of Affordable Healthcare: Can Biosimilars Deliver? As healthcare professionals, we're constantly on the lookout for innovative solutions to improve patient outcomes while reducing costs. One promising approach is the use of biosimilars – bio... Source

Ensuring the Highest Quality in Generic Medications: A Crucial Step in Healthcare As the global demand for affordable healthcare continues to rise, generic medications have become a vital lifeline for millions of people worldwide. However, with the inc... Source

The Unseen Heroes of Generic Medicines: The Crucial Role of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the unsung heroes behind the scenes. But today, I want to shine a spotlight on the Quality Assuranc... Source

Can Lurbinectedin Treat Ovarian Cancer? A Comprehensive Review Ovarian cancer is a devastating disease that affects thousands... https://www.Drugchatter.com/chat/25460/can-lurbinectedin-treat-ovarian-cancer/ Source

Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the quest for affordable and accessible treatmen... Source

Unlock the Secrets of Drug Patent Searching: A Beginner's Guide As a professional in the pharmaceutical industry, staying ahead of the curve is crucial. One of the most critical aspects of this is understanding the world of drug patents. But have you e... Source

Unlocking the Path to Generic Medication Approval: A Step-by-Step Guide As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic medication approval. With the eve... Source

The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, one question on everyone's mind is: how can we make the most of this opportunity? One strategy that's gaining traction is biosimilar-to-biosimilar s... Source

The Hidden Factors Behind FDA-Approved Drugs' Patent Challenges As a healthcare professional or a pharmaceutical industry expert, you're likely no stranger to the complex world of drug patents. But have you ever wondered what sets some FDA-approved dru... Source

Breaking Down Barriers: The Power of Partnerships in Generic Drug Development As the pharmaceutical industry continues to evolve, one thing is clear: collaboration is key. In the world of generic drug development, partnerships are playing an increasing... Source

Does Fish Oil Interact with Vascepa? A Comprehensive Guide As the world becomes increasingly aware of the importance of... https://www.Drugchatter.com/chat/45752/does-fish-oil-interact-with-vascepa/ Source

The Art of Timing: Mastering Generic Drug Development Timelines As a seasoned professional in the pharmaceutical industry, you know that navigating the complex landscape of generic drug development can be a daunting task. One of the most critical facto... Source

The Impact of Lipitor on White Wine: A Comprehensive Guide As a popular cholesterol-lowering medication, Lipitor (atorvastatin)... https://www.Drugchatter.com/chat/37341/how-does-lipitor-affect-white-wine/ Source

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.

With significant growth in activities globally, our /local page has strained to keep up and simply is not a great...